These channels include the hERG K+ channel that is a target for many anti-arrhythmia drugs, as well as the KCNQ K+ channel, and mutations in both of these genes contribute to long QT syndrome (LQTS) which can trigger cardiac arrhythmias and are likely significant contributors to sudden cardiac death. This evidence concerns the gene KCNH2 and Arrhythmia.